3436:TSESUMCO Corporation Analysis
Data as of 2026-08-30 - not real-time
¥3,434.00
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Sumco Corporation trades at ¥3,434.00, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have lost 32.3%. With RSI at 44.4 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at ¥3,210.00 and resistance at ¥4,245.00.
On valuation the read is fair — earnings multiple of 69.8 versus a 35.7 sector average, above the peer group. The average analyst target implies 12.7% above today's level. Revenue is growing at 10.4% on a -6.6% profit margin. The 0.58% dividend yield looks covered by current payout levels.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 105.1%, a beta of 1.84 and a maximum drawdown of 46.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
On valuation the read is fair — earnings multiple of 69.8 versus a 35.7 sector average, above the peer group. The average analyst target implies 12.7% above today's level. Revenue is growing at 10.4% on a -6.6% profit margin. The 0.58% dividend yield looks covered by current payout levels.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 105.1%, a beta of 1.84 and a maximum drawdown of 46.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 2500.39
- MACD momentum is negative
- 30-day price change of -32.3%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 69.8 versus sector average of 35.7
- Trading above the 200-day average of 2500.39
- Analyst targets imply +12.7% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 69.8 versus sector average of 35.7
- Negative profit margin of -6.6%
- Analyst targets imply +12.7% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth10.40%
Profit Margin-6.61%
P/E Ratio69.8
ROE-4.06%
ROA-1.15%
Debt/Equity57.30
P/B Ratio2.1
Op. Cash Flow¥92.9B
Free Cash Flow¥13.2B
Industry P/E35.7
Technical Analysis
TrendNeutral
RSI44.4
Support¥3,210.00
Resistance¥4,245.00
MA 20¥3,575.05
MA 50¥3,951.08
MA 200¥2,500.39
MACDBearish
VolumeDecreasing
Fear & Greed Index95.66
Valuation
Fair Value¥17.13
Target Price¥3,870.00
Upside/Downside12.70%
GradeFair
TypeGrowth
Dividend Yield0.58%
Risk Assessment
Beta1.84
Volatility105.14%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.